Transitional Drugs 3
Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales UHBs & TrustscontractFind a Tender ↗Ref ocds-h6vhtk-04c9a932014L0024active
Estimated value
—
goods
Awarded value
—
Suppliers
11
Lots
1
11 awarded
Published
14 May 2025
Description
Drugs which have recently lost their patent exclusivity
Scope
- Reference
- PAD-OJEU-57920
- Commercial tool
- Standalone contract
- Contract dates
- 31 Mar 2025 to 30 Jun 2026
This framework includes the option to extend for up to a further 24 months
- Main category
- goods
- Contract locations
- Wales
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| Product Quality/Acceptability | Pass/Fail | quality | — |
| Financial (overall cost of contract) | 85 | quality | — |
| Social Value/Community Benefits | 15 | quality | — |
| Price | 85 | cost | — |
Submission & procedure
- Procedure
- Open procedure
Award details· 11 awards
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—